Is John Hancock Multifactor Large Cap ETF (JHML) a Strong ETF Right Now?
Overview of John Hancock Multifactor Large Cap ETF (JHML): Launched in 2015, JHML offers broad exposure to large-cap blend stocks and has accumulated over $905 million in assets, with a focus on sectors like Information Technology. It aims to match the performance of the John Hancock Dimensional Large Cap Index and has an expense ratio of 0.29%.
Performance and Comparison: As of August 2024, JHML has gained approximately 25.35% over the past year, making it a medium-risk investment option. However, investors may also consider lower-cost alternatives like iShares Core S&P 500 ETF (IVV) and SPDR S&P 500 ETF (SPY), which have significantly lower expense ratios.
Trade with 70% Backtested Accuracy
Analyst Views on JHML
About the author

ETF Analysis: The John Hancock Multifactor Large Cap ETF (JHML) has an implied analyst target price of $89.16, indicating a potential upside of 12.32% from its current trading price of $79.38.
Notable Holdings: Key underlying holdings with significant upside potential include Amer Sports Inc (46.29% upside), Match Group Inc (18.80% upside), and First Horizon Corp (14.63% upside) based on their respective analyst target prices.
Market Sentiment: The disparity between current trading prices and analyst target prices raises questions about whether analysts are overly optimistic or justified in their projections for these stocks.
Investor Considerations: Investors are encouraged to conduct further research to assess the validity of analyst targets in light of recent company and industry developments.
ETF Analysis: The John Hancock Multifactor Large Cap ETF (JHML) has an implied analyst target price of $87.80 per unit, indicating a potential upside of 12.08% from its current trading price of $78.34.
Notable Holdings: Key underlying holdings with significant upside potential include Permian Resources Corp (46.80% upside), CAVA Group Inc (41.23% upside), and Smurfit Westrock plc (33.68% upside) based on their respective analyst target prices.
Market Sentiment: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to future downgrades if they do not align with market realities.
Investor Research: It emphasizes the need for further investor research to assess the validity of analyst targets in light of recent company and industry developments.
ETF Analysis: The John Hancock Multifactor Large Cap ETF (JHML) has an implied analyst target price of $86.90 per unit, indicating a potential upside of 13.46% from its current trading price of $76.59.
Notable Holdings: Key underlying holdings with significant upside potential include Klaviyo Inc (87.94% upside), AppFolio Inc (51.87% upside), and Toast Inc (41.90% upside), raising questions about the validity of analysts' target prices and their optimism.
ETF Analysis: The John Hancock Multifactor Large Cap ETF (JHML) has an implied analyst target price of $85.71, indicating a potential upside of 10.84% from its current trading price of $77.33.
Notable Holdings: Key underlying holdings with significant upside potential include FTAI Aviation Ltd, Madrigal Pharmaceuticals Inc, and Ionis Pharmaceuticals Inc, each showing expected price increases based on analyst targets.
ETF Analysis: The John Hancock Multifactor Large Cap ETF (JHML) has an implied analyst target price of $85.44 per unit, indicating a potential upside of 10.23% from its current trading price of $77.51.
Notable Holdings: Key underlying holdings with significant upside potential include Royal Gold Inc (RGLD), Encompass Health Corp (EHC), and Western Alliance Bancorporation (WAL), each showing expected price increases based on analyst targets.
ETF Analysis: The John Hancock Multifactor Large Cap ETF (JHML) has an implied analyst target price of $83.20 per unit, indicating an 11.50% upside from its current trading price of $74.62.
Notable Holdings: Key underlying holdings such as Vaxcyte Inc, Workday Inc, and Omnicom Group show significant potential for growth, with expected price increases of 281.06%, 29.47%, and 28.25% respectively based on analyst targets.










